The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 23,801–23,900 of 31,469
Tan, D. H. S., Raboud, J., Szadkowski, L., et al. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0183 · Cited by 6
Tull, E. S., & Thurland, A. (2004) · PubMed · doi:10.5281/zenodo.22257886 · Cited by 6
Insulin Sensitivity and Secretion in Arab Americans with Glucose Intolerance
Salinitri, F. D., Pinelli, N. R., Martin, E. T., & Jaber, L. A. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0045 · Cited by 6
Association of tyrosine with insulin resistance in hepatitis C virus‐related chronic liver disease
Oono, T., Yamasaki, T., Zaitsu, J., et al. (2013) · Hepatology Research · doi:10.1111/hepr.12213 · Cited by 6
Micić, D., Cvijović, G., Doknić, M., Kendereski, A., & POPOVIC, V. M. (2002) · PubMed · Cited by 6
Zhang, X., Cheng, Z., Xiao, Z. Q., Du, X., Du, J., Yang, L., Long, Y., Yu, H., Zhang, X., & Tian, H. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.06.003 · Cited by 6
MicroRNAs 103 and 107 link type 2 diabetes and post-menopausal breast cancer
Xu, Q., Shang, Y., Li, Y., Zhang, F., Gao, S., & Min-xiu, Y. A. O. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0412-2 · Cited by 6
Liu, Y., Spreng, T., Lehr, M., Yang, B., Karau, A., Gebhardt, H., & Steinacker, J. M. (2015) · Food & Function · doi:10.1039/c5fo00263j · Cited by 6
Prevention of cardiovascular disease in patients with rheumatic diseases
Domsic, R. T., Maksimowicz‐McKinnon, K., & Manzi, S. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.04.005 · Cited by 6
Morita-Suzuki, S., Fujioka, Y., Mitsuoka, H., Tashiro, M., & Harada, M. (2012) · Nutrition and Metabolic Insights · doi:10.4137/nmi.s9683 · Cited by 6
Trifiletti, A., Lasco, A., Scamardi, R., et al. (2002) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000065214 · Cited by 6
Influence of a diet regimen on glucose homeostasis and serum lipid levels in male elite athletes
Tegelman, R., Åberg, T., Eklöf, R., Pousette, Å., Carlström, K., & Berglund, L. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90216-4 · Cited by 6
Huang, T.-T., Du, M., Kuluz, J. W., Li, Y., & Ma, H. (2008) · Hormone Research in Paediatrics · doi:10.1159/000129675 · Cited by 6
Effect of regional fat loss assessed by DXA on insulin resistance and dyslipidaemia in obese women
Aasen, G., Fagertun, H., & Halse, J. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365511003628328 · Cited by 6
Ohn, J. H., Kwon, I. H., Park, J., Ryu, O. H., Lee, S. J., Kim, D. M., Ihm, S., Choi, M. G., Yoo, H. J., & Hong, E. (2014) · Environmental Research · doi:10.1016/j.envres.2014.05.033 · Cited by 7
Obesity in Youth: Implications for the Advanced Practice Nurse in Primary Care
Berry, D., Galasso, P., Melkus, G., & Grey, M. (2004) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2004.tb00455.x · Cited by 6
Diet does not explain the high prevalence of dyslipidaemia in paediatric renal transplant recipients
Siirtola, A., Virtanen, S. M., Ala‐Houhala, M., Koivisto, A., Solakivi, T., Lehtimäki, T. J., Holmberg, C., Antikainen, M., & Salo, M. K. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0660-6 · Cited by 6
de Luis, D. A., Aller, R., Izaola, O., et al. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2008.10.012 · Cited by 6
Kawamoto, R., Tabara, Y., Kohara, K., Miki, T., Kusunoki, T., & Abe, M. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0078 · Cited by 6
Leptin and Insulin Action in Severely Obese Women
Papadia, F. S., Marinari, G. M., Camerini, G. B., Civalleri, D., Scopinaro, N., & Adami, G. (2003) · Obesity Surgery · doi:10.1381/096089203764467135 · Cited by 6
The response of serum apolipoprotein H to an oral fat load
Zahedi, R., Summers, L. K. M., Lumb, P. J., et al. (2004) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563041201482 · Cited by 6
Potential roles for uncoupling proteins in HIV lipodystrophy
Nolan, D. A., & Pace, C. S. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.05.016 · Cited by 6
Costa, D. B., Chen, A. A., Marginean, E. C., et al. (2004) · Endocrine Practice · doi:10.4158/ep.10.5.417 · Cited by 6
Mohammadi, A., Alikhajehlandi, A., & Reddy, P. V. (2014) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/451 · Cited by 6
RARγ and TRβ expressions are decreased in PBMC and SWAT of obese subjects in weight gain
Bairras, C., Redonnet, A., Dabadie, H., Gin, H., Atgié, C., Pallet, V., Higueret, P., & Nöel-Suberville, C. (2010) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-010-0006-x · Cited by 6
Koponen, H., Vuononvirta, J., Maki, P. M., Miettunen, J., Moilanen, I., Taanila, A. M., Ruokonen, A., & Veijola, J. M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.05.021 · Cited by 6
Insulin secretion and impaired glucose tolerance
Jenkins, A. B., & Campbell, L. V. (2010) · Diabetologia · doi:10.1007/s00125-010-1801-1 · Cited by 6
Mohler, E. R., O’Hare, K., Darzé, E. S., Townsend, R. R., Bridges, C. R., & Keane, M. G. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.06635.x · Cited by 6
Ghrelin and Leptin Response to Oral Glucose Challenge Among Antipsychotic Drug-Treated Children
Winsberg, B. G., Usubiaga, H., & Cooper, T. M. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815a4437 · Cited by 6
Carranza, A., Litterio, M. C., Prince, P. D., Mayer, M. A., Ingaramo, P. I., Ronco, M. T., Peredo, H. A., Puyó, A. M., & Galleano, M. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.12.005 · Cited by 6
Choi, J. R., Kwon, I., Kwon, D. Y., et al. (2013) · Genomics & Informatics · doi:10.5808/gi.2013.11.4.263 · Cited by 6
de Luis, D. A., Sagrado, M. G., Conde, R., Aller, R., Izaola, O., & Romero, E. (2007) · Annals of Nutrition and Metabolism · doi:10.1159/000111160 · Cited by 6
Ryomoto, K., Suzuki, M., Kanazawa, A., Hasegawa, M., Kimura, Y., Yamamura, T., & Harano, Y. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00256-3 · Cited by 6
Acanthosis Nigricans During Treatment With Aripiprazole
Manu, P., Al-Dhaher, Z., Dargani, N., & Correll, C. U. (2012) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3182491e29 · Cited by 7
Tucker, L. A., & Tucker, J. M. (2012) · Obesity · doi:10.1038/oby.2012.44 · Cited by 6
Plasma testosterone in adult normoglycaemic men: impact of hyperinsulinaemia
Praveen, E. P., Khurana, M. L., Kulshreshtha, B., Dwivedi, S. N., Prabhakaran, D., Khadgawat, R., Gupta, N., Kumar, G. S. H., & Ammini, A. C. (2012) · Andrologia · doi:10.1111/j.1439-0272.2012.01278.x · Cited by 7
Kuba, V. M., Cavalieri, P. M., Christóforo, Â. C., Faria, R., Caetano, R., Coeli, C. M., & Athayde, A. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000600008 · Cited by 6
Mori, Y., Hoshino, K., Yokota, K., Itoh, Y., & Tajima, N. (2006) · Endocrine · doi:10.1385/endo:29:2:351 · Cited by 6
High Incidence of Insulin Resistance and Dysglycemia Amongst Nondiabetic Cardiac Surgical Patients
Hofferberth, S. C., Newcomb, A. E., Ryan, M. C., Yii, M. Y., Nixon, I. K., Rosalion, A., Boston, R. C., Ward, G. M., & Wilson, A. (2012) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.01.101 · Cited by 6
Additional Effect of Visceral Fat Resection in an Obese Rat Model of Gastric Banding
Endo, Y., Ohta, M., Hirashita, T., Eguchi, H., Kai, S., & Kitano, S. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9613-9 · Cited by 6
Variability in HOMA‐IR, Lipoprotein Profile and Selected Hormones in Young Active Men
Kęska, A., Lutosławska, G., Czajkowska, A., Tkaczyk, J., & Mazurek, K. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/412764 · Cited by 6
de Koning, L., Merchant, A. T., Hegele, R. A., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.106682 · Cited by 6
Kaku, K., Kawasaki, F., Kanda, Y., et al. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.10.020 · Cited by 6
Maekawa, K., Tsujino, T., Saito, K., Kim, J., Ikeda, Y., Emoto, N., & Yokoyama, M. (2006) · Heart and Vessels · doi:10.1007/s00380-005-0889-6 · Cited by 5
Hwu, C., Lin, M., Liou, T., Hsiao, L., Liang, K.-W., Tsai, T.-T., & Ho, L. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31800577856 · Cited by 7
Wägner, A. M., Ordóñez‐Llanos, J., Arcelús, R., et al. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00090-8 · Cited by 6
Gençtoy, G., Kahraman, S., Arıcı, M., et al. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.01.041 · Cited by 6
Manzella, D., Grella, R., Esposito, K., Cacciapuoti, F., Arciello, A., Giugliano, D., & Paolisso, G. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.12.006 · Cited by 6
Metabolic Syndrome Is a Risk Factor for Coronary Artery Disease in a Tunisian Population
Rejeb, J., Omezzine, A., Boumaiza, I., Rebhi, L., Kalboussi, N., Laouini, A., Rejeb, N. B., Nabli, N., Abdelaziz, A. B., Boughzala, E., et al. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0020 · Cited by 6
Rhee, E., Seo, M. H., Jeon, W. S., Won, H. K., Choi, J., Park, S. E., Park, C., Kwag, H. J., Oh, K.-W., Park, S. W., et al. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.022 · Cited by 7
13-cis-Retinoic Acid (Isotretinoin) Unmasking of Clinical Polycystic Ovary Syndrome
Pham, T., & Scofield, R. H. (2007) · Endocrine Practice · doi:10.4158/ep.13.7.776 · Cited by 5
Effect of hormone therapy on the elastic properties of the arteries in healthy postmenopausal women
Tentolouris, N., Christodoulakos, G., Lambrinoudaki, I. V., Mandalaki, E., Panoulis, C., Maridaki, C., Creatsas, G. C., & Katsilambros, N. L. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347195 · Cited by 6
Gottsäter, M., Länne, T., & Nilsson, P. M. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2013.126 · Cited by 6
Metabolic profiles of fat and glucose differ by gender in healthy 8‐year‐olds
Eriksson, S., Pálsdóttir, V., Garemo, M., et al. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2009.01513.x · Cited by 6
Subclinical Atherosclerosis and Metabolic Risk: Role of Body Mass Index and Waist Circumference
Camhi, S. M., Katzmarzyk, P. T., Broyles, S. T., Srinivasan, S. R., Chen, W., Bouchard, C., & Berenson, G. S. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0079 · Cited by 6
Son, H., Han, J., & Lee, J. (2014) · Korean Journal of Food Preservation · doi:10.11002/kjfp.2014.21.4.549 · Cited by 6
Low Physical Function as a Risk Factor for Incident Diabetes Mellitus and Insulin Resistance
Longenberger, A. H., Lim, J. Y., Brown, T. T., Abraham, A. G., Palella, F. J., Effros, R. B., Orchard, T. J., Brooks, M. M., & Kingsley, L. (2011) · Future Virology · doi:10.2217/fvl.11.15 · Cited by 6
Decrease in sE-Selectin after Pituitary Surgery in Patients with Acromegaly
Schmid, C., Wiesli, P., Bernays, R. L., Bloch, K. E., Zapf, J., Zwimpfer, C., Ghirlanda-Keller, C., & Brändle, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.028779 · Cited by 6
Coté, A. T., Devlin, A. M., & Panagiotopoulos, C. (2014) · Pediatric Exercise Science · doi:10.1123/pes.2014-0076 · Cited by 6
Ritt, M., Piza, H., Rhomberg, M., Aigner, F., & Lechleitner, M. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00415.x · Cited by 6
Lindgärde, F., Gottsäter, A., & Åhrén, B. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-38 · Cited by 6
Ferraroni, N. R., Geloneze, B., Mansour, E., et al. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02300.x · Cited by 6
Theodoridou, K., Margeli, A., Spoulou, V. I., Bathrellou, I., Skevaki, C. L., Chrousos, G. P., Papassotiriou, I., & Kanaka‐Gantenbein, C. (2013) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2013.859725 · Cited by 6
Vivian Gallardo, T., Alejandra Ávila, A., Nancy Unanue, M., & Ethel Codner, D. (2006) · Revista médica de Chile · doi:10.4067/s0034-98872006000900009 · Cited by 6
de Luis, D. A., Sagrado, M. G., Aller, R., Conde, R., Izaola, O., de la Fuente, B., & Primo, D. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.12.006 · Cited by 6
Hsieh, C., Hung, Y., Wu, D., Kuo, S., Lee, C.-H., Sheu, W. H., Li, J.-C., Yeh, K.-H., Chen, C., & Pei, D. (2007) · Journal of Korean Medical Science · doi:10.3346/jkms.2007.22.1.74 · Cited by 6
Seccia, T. M., & Rossi, G. P. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500295600 · Cited by 6
Primary Hypercholesterolemia, Carotid Atherosclerosis and Insulin Resistance Among Chinese
Chien, K., Liau, C., Chen, M.-F., Lee, Y., Jeng, J., Hwang, B., & Su, T. (2007) · Lipids · doi:10.1007/s11745-007-3138-1 · Cited by 6
Light-to-moderate alcohol consumption, risk factor profile and early atherosclerosis: the RIAD Study
Temelkova-Kurktschiev, T. S., Henkel, E., Koehler, C., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00481-6 · Cited by 6
Türker, İ., Demirağ, N. G., Tanaci, N., Tutar, N. U., & Kırbaş, İ. (2006) · Current Therapeutic Research · doi:10.1016/j.curtheres.2006.06.001 · Cited by 6
Lee, K. (2009) · Public Health Nutrition · doi:10.1017/s1368980009991340 · Cited by 6
Katzeff, H. L., Williams‐Herman, D., Xu, L., Golm, G. T., Wang, H., Dong, Q., JOHNSON, J. R., O’Neill, E. A., Kaufman, K. D., Engel, S. S., et al. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1037259 · Cited by 7
Suárez, R. M. G., Amador, P., & Calzado, C. M. A. (2010) · Revista cubana de endocrinología · Cited by 5
Vendramini, M. F., Kasamatsu, T. S., Crispim, F., Ferreira, S. R. G., Matioli, S. R., Japanese‐Brazilian Diabetes Study Group, & Moisés, R. S. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03439.x · Cited by 6
Torre, E. L. M., Valdés, S., Botas, P., Delgado, E., & Abello, N. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.10.003 · Cited by 5
Resting energy expenditure and insulin resitance in obese patients, differences in women and men.
de Luis, D. A., Aller, R., & Izaola, O. (2007) · PubMed · Cited by 6
Olmo-García, M. I. D., Merino-Torres, J. F., Argente, M., Molina-Ramos, A. I., Navas, M., Campos, V., Cámara, R., & Pérez-Lázaro, A. (2012) · PubMed · doi:10.3275/7769 · Cited by 6
A study on glucose metabolism in a small cohort of children and adolescents with kidney transplant
Giordano, M., Colella, V., Dammacco, A., Torelli, C., Grandaliano, G., Teutonico, A., Depalo, T., Caringella, D. A., & Paolo, S. D. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344104 · Cited by 5
Stéatopathie métabolique : prise en charge
Pariente, A. E. (2009) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2009.02.028 · Cited by 5
Mamza, Y. P. (2013) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-0715357 · Cited by 6
강설중, & Jung, S.-L. (2010) · Exercise Science · doi:10.15857/ksep.2010.19.3.277 · Cited by 6
Philosophe, B., Farney, A. C., Schweitzer, E. J., Colonna, J. O., Jarrell, B. E., Foster, C., Wiland, A., & Bartlett, S. T. (2000) · PubMed · Cited by 6
Suarez, E. C., Beckham, J. C., & Green, K. T. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-017-9652-5 · Cited by 6
Post-Prandial Plasma Glucose Less Than or Equal to 70 mg/dL Is Not Uncommon in Young Japanese Women
Tsuboi, A., Takeuchi, M., Kitaoka, K., Minato, S., Kurata, M., Kazumi, T., & Fukuo, K. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3069w · Cited by 6
Blais, S., Patenaude, J., Doyon, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207632 · Cited by 6
Fujikura, K., Heydari, B., Ge, Y., Kaneko, K., Abdullah, S. M., Harris, W. S., Jerosch‐Herold, M., & Kwong, R. Y. K. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.11.032 · Cited by 6
Lien, L. F., & Guyton, J. R. (2008) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.00218.x · Cited by 7
Hitsumoto, T. (2019) · Cardiology Research · doi:10.14740/cr878 · Cited by 6
Insulin resistance and hypertension in postmenopausal women
Feldstein, C. A., Akopian, M., Renauld, A., Olivieri, A. O., Cauterucci, S., & Garrido, D. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001362 · Cited by 6
[Oxidized LDL and anti-oxidized LDL antibodies according uric acid levels in overweight women].
Ruiz, N., Espinoza, M., González, J. C., et al. (2015) · PubMed · Cited by 6
Pei, D., Hung, Y., Chen, H.-D., Hsiao, C., Fu, C.-C., Yang, T.-C., Lian, W., Fang, S. C., Hsu, W., & Kuo, S. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.04.006 · Cited by 6
Lerman, I. G., Villa, A. R., Torres, J., Tamez-Gutiérrez, L. E., Pérez, F. G., Velasco, S. L. D. V., & Rodrigo, J. A. R. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00201-5 · Cited by 6
Cheung, B. M. Y., Leung, R. Y. H., Man, Y. B., et al. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002003 · Cited by 6
Rivas‐Crespo, M. F. (2015) · Diabetes Care · doi:10.2337/dc15-1172 · Cited by 6
The hypertriglyceridaemic waist in New Zealand Maori.
Bell, D. A., McAuley, K. A., Mann, J. I., Murphy, E., & Williams, S. (2004) · PubMed · Cited by 6
Mousavinasab, F. (2007) · Cited by 6
Green, C., Pramfalk, C., Charlton, C. A., Gunn, P. J., Cornfield, T., Pavalides, M., Karpe, F., & Hodson, L. (2019) · Endocrine Abstracts · doi:10.1530/endoabs.65.oc1.2 · Cited by 6
Sultanov, B. A., Хайдарова, Ф. А., & Ismailov, S. I. (2004) · Endocrine Practice · doi:10.4158/ep.10.s1.1 · Cited by 6
Cheshmeh, S., Elahi, N., Ghayyem, M., Mosayebi, E., Moradi, S., Pasdar, Y., & Tahmasebi, S. (2021) · Research Square · doi:10.21203/rs.3.rs-172896/v1 · Cited by 6
Alruwaili, A., Nayeemullah, R., Engin, B., Malaikah, S., James, L., Sanders, J. P., Thivel, D., Thackray, A. E., Stensel, D. J., King, J. A., et al. (2025) · Appetite · doi:10.1016/j.appet.2025.108194 · Cited by 6
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
